Effect of growth hormone on high plasma levels of glucagon-like peptide-1 (GLP-1) in hypophysectomized rats

被引:4
|
作者
Tateishi, K
Kitayama, N
Ishikawa, H
Mitsudome, A
Hirose, S
机构
[1] Fukuoka Univ, Sch Med, Dept Biochem, Jonan Ku, Fukuoka 8140180, Japan
[2] Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 81401, Japan
[3] JCR Pharmaceut Co Ltd, Kobe, Hyogo, Japan
关键词
hypophysectomized rat; plasma GLP-1; GH; oral glucose tolerance test;
D O I
10.1055/s-2002-34994
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fasting plasma GLP-1 levels were significantly higher in hypophysectomized (hypox) rats (n=6) than in intact (normal) rats (n=7) (54.3+/-5.2 vs. 33.3+/-2.4 pmol/L, p<0.001). To examine the influence of pituitary hormones on plasma GLP-1 levels, concentrations of plasma glucose, insulin and GLP-1 after an oral glucose load to hypox rats that were given either rat growth hormone (rGH) (n=7), cortisol and thyroxine (n=7) or no substitution (n=6) were compared with those of normal rats (n=7). Plasma glucose levels in the fasting state and after the glucose ingestion were significantly lower in hypox rats, but the patterns were different from those in normal rats. Insulin levels both in the fasting state and after the glucose ingestion were significantly decreased in hypox rats and the fasting and total GLP-1 levels were significantly increased in those rats. rGH substitution significantly increased the total insulin levels in hypox rats and decreased the fasting and total GLP-1 levels closely to levels in normal rats, while substitution with cortisol and thyroxine failed to introduce such a significant effect. These results suggested that secretion of GLP-1 might be influenced by the function of GH.
引用
收藏
页码:361 / 363
页数:3
相关论文
共 50 条
  • [1] Peripheral Glucagon-like Peptide-1 (GLP-1) and Satiation
    Punjabi, Mukesh
    Arnold, Myrtha
    Geary, Nori
    Langhans, Wolfgang
    Pacheco-Lopez, Gustavo
    PHYSIOLOGY & BEHAVIOR, 2011, 105 (01) : 71 - 76
  • [2] The human glucagon-like peptide-1 (GLP-1) receptor
    Dillon, JS
    Wheeler, MB
    Leng, XH
    Ligon, BB
    Boyd, AE
    PHYSIOLOGY AND PATHOPHYSIOLOGY OF THE ISLETS OF LANGERHANS, 1997, 426 : 113 - 119
  • [3] THE COLON AS A SOURCE FOR GLUCAGON-LIKE PEPTIDE-1 (GLP-1)
    HOLST, JJ
    OLESEN, KM
    GUDMANDHOYER, E
    DEACON, CF
    HANSEN, CP
    JOHNSEN, AH
    MIHOLIC, J
    NAUCK, M
    QUALMANN, C
    DIABETOLOGIA, 1995, 38 : A170 - A170
  • [4] Facile Synthesis of Glucagon-Like Peptide-1 (GLP-1) Mimetics
    Han, Sun-Young
    Beinborn, Martin
    Ahn, Jung-Mo
    PEPTIDES FOR YOUTH, 2009, 611 : 119 - 120
  • [5] Facile synthesis of glucagon-like peptide-1 (GLP-1) mimetics
    Han, S.-Y.
    Murage, E.
    Beinbom, M.
    Ahn, J.-M.
    BIOPOLYMERS, 2007, 88 (04) : 560 - 560
  • [6] Glucagon-like peptide-1 drugs Are GLP-1 analogues affordable?
    Macaulay, Donald
    BRITISH MEDICAL JOURNAL, 2011, 342
  • [7] GLUCAGON-LIKE PEPTIDE-1 (GLP-1) - A PIECE OF THE INCRETIN PUZZLE
    WEIR, GC
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01): : 1 - 1
  • [8] Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
    Hoelscher, Christian
    CNS DRUGS, 2012, 26 (10) : 871 - 882
  • [9] Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
    Christian Hölscher
    CNS Drugs, 2012, 26 : 871 - 882
  • [10] Glucagon-like peptide 1 (GLP-1)
    Mueller, T. D.
    Finan, B.
    Bloom, S. R.
    D'Alessio, D.
    Drucker, D. J.
    Flatt, P. R.
    Fritsche, A.
    Gribble, F.
    Grill, H. J.
    Habener, J. F.
    Holst, J. J.
    Langhans, W.
    Meier, J. J.
    Nauck, M. A.
    Perez-Tilve, D.
    Pocai, A.
    Reimann, F.
    Sandoval, D. A.
    Schwartz, T. W.
    Seeley, R. J.
    Stemmer, K.
    Tang-Christensen, M.
    Woods, S. C.
    DiMarchi, R. D.
    Tschoep, M. H.
    MOLECULAR METABOLISM, 2019, 30 : 72 - 130